Featured Research

from universities, journals, and other organizations

With certain preventive measures, incidence of deep vein thrombosis after general surgery appears low, possibly catheter-related

Date:
August 15, 2011
Source:
JAMA and Archives Journals
Summary:
The incidence of deep vein thrombosis (DVT) after general surgical operations seems to be low when preventive steps are taken, but most cases that do occur are diagnosed in the inpatient setting and most are associated with catheter use, according to a new report.

The incidence of deep vein thrombosis (DVT) after general surgical operations seems to be low when preventive steps are taken, but most cases that do occur are diagnosed in the inpatient setting and most are associated with catheter use, according to a report published Online First by Archives of Surgery, one of the JAMA/Archives journals.

A blood clot that forms in a deep vein, DVT occurs in up to 40 percent of general surgery patients with an associated death risk of 1 percent unless protective steps (prophylaxis) are taken, according to background information in the article. Historically, some surgeons have been resistant to using anticoagulant (anticlotting) medications that protect against DVT because of concern about bleeding, although recent research suggests that prevention is associated with significant reductions in DVT and a low rate of major bleeding. "Few data exist regarding the specifics of DVT formation when general surgical patients receive adequate prophylaxis," write the authors.

Brian R. Smith, M.D., and colleagues in the Department of Surgery at University of California, Irvine Medical Center, Orange, Calif., reviewed data from the National Surgical Quality Improvement Program from January 2008 to December 2009. The researchers evaluated medical records to assess patient characteristics and demographics, whether a central catheter was in place, the location of DVT, the time of diagnosis from the index operation, whether any DVT were associated with clots in the lungs (pulmonary embolism) and how many deaths occurred.

During the study period 2,189 patients underwent general operations (including surgeries of the pancreas, esophagus, stomach, intestines, colon and rectum, as well as other body parts) and 35 (1.6 percent) developed DVT. Most cases (94.3 percent) of DVT were detected because patients experienced DVT symptoms; the rest were found through routine screening. Similar numbers of patients developed upper-extremity DVT (40 percent) or lower-extremity DVT (45.7 percent), and 14.3 percent developed DVT in both areas. DVT was diagnosed a mean (average) of 8.6 days after the operation, and in 83 percent of cases was diagnosed in the inpatient setting. DVT associated with catheters occurred in 60 percent of patients. Other underlying health problems were noted in 62.9 percent of patients, including pulmonary embolism in 11.4 percent. At 30 days, the death rate was 14.2 percent. The researchers reported an average 93 percent compliance with prophylaxis criteria during the study period.

"The incidence of DVT after general surgical operations is low, with most cases diagnosed as inpatients," the authors conclude. "With more than half of DVTs being caused by central catheters, efforts toward DVT prevention should include closer scrutiny to the need for central catheters, including limiting the duration of central catheters, and consideration of the added use or perhaps higher dose of anticoagulation when central catheters are present."


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. Brian R. Smith; Sidney Diniz; Michael Stamos; Ninh T. Nguyen. Deep Venous Thrombosis After General Surgical Operations at a University Hospital: Two-Year Data From the ACS NSQIP. Archives of Surgery, 2011; DOI: 10.1001/archsurg.2011.204

Cite This Page:

JAMA and Archives Journals. "With certain preventive measures, incidence of deep vein thrombosis after general surgery appears low, possibly catheter-related." ScienceDaily. ScienceDaily, 15 August 2011. <www.sciencedaily.com/releases/2011/08/110815195904.htm>.
JAMA and Archives Journals. (2011, August 15). With certain preventive measures, incidence of deep vein thrombosis after general surgery appears low, possibly catheter-related. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/08/110815195904.htm
JAMA and Archives Journals. "With certain preventive measures, incidence of deep vein thrombosis after general surgery appears low, possibly catheter-related." ScienceDaily. www.sciencedaily.com/releases/2011/08/110815195904.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins